volume 24, issue 3, P541-555 2010
DOI: 10.1016/j.idc.2010.04.005
View full text
|
|
Share
Shawn P.E. Nishi, Vincent G. Valentine, Steve Duncan

Abstract: Kidney, liver, heart, pancreas, lung, and small intestine transplantations are viable therapeutic options for patients with end-stage organ failure. Ongoing advancements of surgical techniques, immunosuppressive regimens, and perioperative management have resulted in improved survival of allograft recipients. Despite these refinements, infections still contribute to substantial morbidity and mortality, limiting long-term success rates of these procedures. This article discusses the emerging bacterial, fungal, …

expand abstract